Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.
about
Schisandrin B Prevents Hind Limb from Ischemia-Reperfusion-Induced Oxidative Stress and Inflammation via MAPK/NF-κB Pathways in Rats.Protective effects of carnosic acid against mitochondria-mediated injury in H9c2 cardiomyocytes induced by hypoxia/reoxygenation.MicroRNA‑206 contributes to the progression of steroid‑induced avascular necrosis of the femoral head by inducing osteoblast apoptosis by suppressing programmed cell death 4.MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway.
P2860
Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@en
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@nl
type
label
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@en
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@nl
prefLabel
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@en
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@nl
P2093
P2860
P356
P1476
Gypenoside Protects Cardiomyoc ...... Pathway In Vitro and In Vivo.
@en
P2093
P2860
P356
10.3389/FPHAR.2016.00148
P577
2016-06-01T00:00:00Z